Transversus abdominis plane block, intravenous lignocaine or placebo for postoperative analgesia after open prostate surgery: a randomized controlled trial
- Conditions
- Prostate surgeryTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
- Registration Number
- EUCTR2010-018321-20-BE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
Open prostate surgery
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 40
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 80
Exclusion Criteria
Allergy to study medication
OSA
Renal or liver failure
Seizure
Heart block
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Compare the analgesic efficacy of TAP bloc, intravenous lidocaine and placebo after open prostate surgery;Secondary Objective: Not Applicable;Primary end point(s): Cumulative piritramide consumption after 48 hours;Timepoint(s) of evaluation of this end point: 48 hours
- Secondary Outcome Measures
Name Time Method Secondary end point(s): Pain scores at rest and upon couging<br>Bowel function recovery<br>Nausea and vomiting<br>Rescue analgesia<br>Bladder catheter-related pain;Timepoint(s) of evaluation of this end point: hospital discharge